The 6 month interim analysis of a randomized controlled trial assessing the quality of life in patients with breast cancer related lymphedema undergoing lymphaticovenous anastomosis vs. conservative therapy
Abstract Breast cancer related lymphedema (BCRL) is a chronic condition with a detrimental impact on psychosocial and physical well-being. Lymphaticovenous anastomosis has shown promising results in alleviating physical symptoms and increasing quality of life in patients with BCRL. The aim of the st...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-01-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-024-52489-3 |
| _version_ | 1797276627507347456 |
|---|---|
| author | Y. M. J. Jonis J. A. G. N. Wolfs S. Hummelink H. J. P. Tielemans X. H. A. Keuter S. van Kuijk D. J. O. Ulrich R. R. W. J. van der Hulst S. S. Qiu |
| author_facet | Y. M. J. Jonis J. A. G. N. Wolfs S. Hummelink H. J. P. Tielemans X. H. A. Keuter S. van Kuijk D. J. O. Ulrich R. R. W. J. van der Hulst S. S. Qiu |
| author_sort | Y. M. J. Jonis |
| collection | DOAJ |
| description | Abstract Breast cancer related lymphedema (BCRL) is a chronic condition with a detrimental impact on psychosocial and physical well-being. Lymphaticovenous anastomosis has shown promising results in alleviating physical symptoms and increasing quality of life in patients with BCRL. The aim of the study is to evaluate the effect on health related quality of life (HrQol) after LVA surgery versus conservative treatment in patients with BCRL. The study is a prospective, multicenter randomized controlled trial. Adult women with unilateral BCRL, with early stage lymphedema and viable lymphatic vessels were included. The primary outcome measure was HrQol measured by the lymphedema functioning disability and health (Lymph-ICF) questionnaire. The secondary outcomes were volume difference measured by the water displacement method; the Upper Extremity Lymphedema (UEL) index; and daily use of the compression garments after 3 and 6 months. For this interim analysis 46 patients per group were included. There was a significant improvement in the domains in physical and mental function in the Lymph-ICF questionnaire in the LVA group after 6 months, (− 16.46 ± 18.5, p < 0.05, − 10.12 ± 29.5, p < 0.05 respectively). However, there was no statistical difference in the total score of the Lymph-ICF after 6 months in both groups (LVA-group; − 8.57 ± 22.6, p > 0.05, CDT-group; − 2.65 ± 18.2, p < 0.05). Furthermore, there was no significant volume reduction in both groups (LVA-group: 20.04 ± 196.40, p = 0.497, CDT: 33.98 ± 189.87, p = 0.236). In the LVA group, 41% partially of completely stopped wearing the compression garments after six months whereas in the CDT group 0% discontinued to use of compression garments. LVA resulted in improvement of the domains physical and mental function of the Lymph-ICF. Limb volume did not significantly improve after 6 months. However, around 42% could completely or partially stopped with the use of compression garments in the LVA group. The current results are promising, however longer follow up is required to assess long term effect of LVA for secondary lymphedema. Clinical Trial Registration: NCT02790021 registered on 03/06/2016 |
| first_indexed | 2024-03-07T15:30:57Z |
| format | Article |
| id | doaj.art-a46de059a66243cfa23db686e41a4f09 |
| institution | Directory Open Access Journal |
| issn | 2045-2322 |
| language | English |
| last_indexed | 2024-03-07T15:30:57Z |
| publishDate | 2024-01-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj.art-a46de059a66243cfa23db686e41a4f092024-03-05T16:25:14ZengNature PortfolioScientific Reports2045-23222024-01-011411910.1038/s41598-024-52489-3The 6 month interim analysis of a randomized controlled trial assessing the quality of life in patients with breast cancer related lymphedema undergoing lymphaticovenous anastomosis vs. conservative therapyY. M. J. Jonis0J. A. G. N. Wolfs1S. Hummelink2H. J. P. Tielemans3X. H. A. Keuter4S. van Kuijk5D. J. O. Ulrich6R. R. W. J. van der Hulst7S. S. Qiu8Department of Plastic, Reconstructive, and Hand Surgery, Maastricht University Medical CenterDepartment of Plastic, Reconstructive, and Hand Surgery, Maastricht University Medical CenterDepartment of Plastic and Reconstructive Surgery, Radboud University Medical CenterDepartment of Plastic and Reconstructive Surgery, Radboud University Medical CenterDepartment of Plastic, Reconstructive, and Hand Surgery, Maastricht University Medical CenterDepartment of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical CenterDepartment of Plastic and Reconstructive Surgery, Radboud University Medical CenterDepartment of Plastic, Reconstructive, and Hand Surgery, Maastricht University Medical CenterDepartment of Plastic, Reconstructive, and Hand Surgery, Maastricht University Medical CenterAbstract Breast cancer related lymphedema (BCRL) is a chronic condition with a detrimental impact on psychosocial and physical well-being. Lymphaticovenous anastomosis has shown promising results in alleviating physical symptoms and increasing quality of life in patients with BCRL. The aim of the study is to evaluate the effect on health related quality of life (HrQol) after LVA surgery versus conservative treatment in patients with BCRL. The study is a prospective, multicenter randomized controlled trial. Adult women with unilateral BCRL, with early stage lymphedema and viable lymphatic vessels were included. The primary outcome measure was HrQol measured by the lymphedema functioning disability and health (Lymph-ICF) questionnaire. The secondary outcomes were volume difference measured by the water displacement method; the Upper Extremity Lymphedema (UEL) index; and daily use of the compression garments after 3 and 6 months. For this interim analysis 46 patients per group were included. There was a significant improvement in the domains in physical and mental function in the Lymph-ICF questionnaire in the LVA group after 6 months, (− 16.46 ± 18.5, p < 0.05, − 10.12 ± 29.5, p < 0.05 respectively). However, there was no statistical difference in the total score of the Lymph-ICF after 6 months in both groups (LVA-group; − 8.57 ± 22.6, p > 0.05, CDT-group; − 2.65 ± 18.2, p < 0.05). Furthermore, there was no significant volume reduction in both groups (LVA-group: 20.04 ± 196.40, p = 0.497, CDT: 33.98 ± 189.87, p = 0.236). In the LVA group, 41% partially of completely stopped wearing the compression garments after six months whereas in the CDT group 0% discontinued to use of compression garments. LVA resulted in improvement of the domains physical and mental function of the Lymph-ICF. Limb volume did not significantly improve after 6 months. However, around 42% could completely or partially stopped with the use of compression garments in the LVA group. The current results are promising, however longer follow up is required to assess long term effect of LVA for secondary lymphedema. Clinical Trial Registration: NCT02790021 registered on 03/06/2016https://doi.org/10.1038/s41598-024-52489-3 |
| spellingShingle | Y. M. J. Jonis J. A. G. N. Wolfs S. Hummelink H. J. P. Tielemans X. H. A. Keuter S. van Kuijk D. J. O. Ulrich R. R. W. J. van der Hulst S. S. Qiu The 6 month interim analysis of a randomized controlled trial assessing the quality of life in patients with breast cancer related lymphedema undergoing lymphaticovenous anastomosis vs. conservative therapy Scientific Reports |
| title | The 6 month interim analysis of a randomized controlled trial assessing the quality of life in patients with breast cancer related lymphedema undergoing lymphaticovenous anastomosis vs. conservative therapy |
| title_full | The 6 month interim analysis of a randomized controlled trial assessing the quality of life in patients with breast cancer related lymphedema undergoing lymphaticovenous anastomosis vs. conservative therapy |
| title_fullStr | The 6 month interim analysis of a randomized controlled trial assessing the quality of life in patients with breast cancer related lymphedema undergoing lymphaticovenous anastomosis vs. conservative therapy |
| title_full_unstemmed | The 6 month interim analysis of a randomized controlled trial assessing the quality of life in patients with breast cancer related lymphedema undergoing lymphaticovenous anastomosis vs. conservative therapy |
| title_short | The 6 month interim analysis of a randomized controlled trial assessing the quality of life in patients with breast cancer related lymphedema undergoing lymphaticovenous anastomosis vs. conservative therapy |
| title_sort | 6 month interim analysis of a randomized controlled trial assessing the quality of life in patients with breast cancer related lymphedema undergoing lymphaticovenous anastomosis vs conservative therapy |
| url | https://doi.org/10.1038/s41598-024-52489-3 |
| work_keys_str_mv | AT ymjjonis the6monthinterimanalysisofarandomizedcontrolledtrialassessingthequalityoflifeinpatientswithbreastcancerrelatedlymphedemaundergoinglymphaticovenousanastomosisvsconservativetherapy AT jagnwolfs the6monthinterimanalysisofarandomizedcontrolledtrialassessingthequalityoflifeinpatientswithbreastcancerrelatedlymphedemaundergoinglymphaticovenousanastomosisvsconservativetherapy AT shummelink the6monthinterimanalysisofarandomizedcontrolledtrialassessingthequalityoflifeinpatientswithbreastcancerrelatedlymphedemaundergoinglymphaticovenousanastomosisvsconservativetherapy AT hjptielemans the6monthinterimanalysisofarandomizedcontrolledtrialassessingthequalityoflifeinpatientswithbreastcancerrelatedlymphedemaundergoinglymphaticovenousanastomosisvsconservativetherapy AT xhakeuter the6monthinterimanalysisofarandomizedcontrolledtrialassessingthequalityoflifeinpatientswithbreastcancerrelatedlymphedemaundergoinglymphaticovenousanastomosisvsconservativetherapy AT svankuijk the6monthinterimanalysisofarandomizedcontrolledtrialassessingthequalityoflifeinpatientswithbreastcancerrelatedlymphedemaundergoinglymphaticovenousanastomosisvsconservativetherapy AT djoulrich the6monthinterimanalysisofarandomizedcontrolledtrialassessingthequalityoflifeinpatientswithbreastcancerrelatedlymphedemaundergoinglymphaticovenousanastomosisvsconservativetherapy AT rrwjvanderhulst the6monthinterimanalysisofarandomizedcontrolledtrialassessingthequalityoflifeinpatientswithbreastcancerrelatedlymphedemaundergoinglymphaticovenousanastomosisvsconservativetherapy AT ssqiu the6monthinterimanalysisofarandomizedcontrolledtrialassessingthequalityoflifeinpatientswithbreastcancerrelatedlymphedemaundergoinglymphaticovenousanastomosisvsconservativetherapy AT ymjjonis 6monthinterimanalysisofarandomizedcontrolledtrialassessingthequalityoflifeinpatientswithbreastcancerrelatedlymphedemaundergoinglymphaticovenousanastomosisvsconservativetherapy AT jagnwolfs 6monthinterimanalysisofarandomizedcontrolledtrialassessingthequalityoflifeinpatientswithbreastcancerrelatedlymphedemaundergoinglymphaticovenousanastomosisvsconservativetherapy AT shummelink 6monthinterimanalysisofarandomizedcontrolledtrialassessingthequalityoflifeinpatientswithbreastcancerrelatedlymphedemaundergoinglymphaticovenousanastomosisvsconservativetherapy AT hjptielemans 6monthinterimanalysisofarandomizedcontrolledtrialassessingthequalityoflifeinpatientswithbreastcancerrelatedlymphedemaundergoinglymphaticovenousanastomosisvsconservativetherapy AT xhakeuter 6monthinterimanalysisofarandomizedcontrolledtrialassessingthequalityoflifeinpatientswithbreastcancerrelatedlymphedemaundergoinglymphaticovenousanastomosisvsconservativetherapy AT svankuijk 6monthinterimanalysisofarandomizedcontrolledtrialassessingthequalityoflifeinpatientswithbreastcancerrelatedlymphedemaundergoinglymphaticovenousanastomosisvsconservativetherapy AT djoulrich 6monthinterimanalysisofarandomizedcontrolledtrialassessingthequalityoflifeinpatientswithbreastcancerrelatedlymphedemaundergoinglymphaticovenousanastomosisvsconservativetherapy AT rrwjvanderhulst 6monthinterimanalysisofarandomizedcontrolledtrialassessingthequalityoflifeinpatientswithbreastcancerrelatedlymphedemaundergoinglymphaticovenousanastomosisvsconservativetherapy AT ssqiu 6monthinterimanalysisofarandomizedcontrolledtrialassessingthequalityoflifeinpatientswithbreastcancerrelatedlymphedemaundergoinglymphaticovenousanastomosisvsconservativetherapy |